Event Calendar

Dec 15, 2020

PETAH TIKVA, Israel, Dec. 03, 2020 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD), a Phase 3 clinical-stage biopharmaceutical company focused on developing targeted, locally administered, and prolonged-release therapeutics using its proprietary PLEX technology, today announced that it will host a key opinion leader (KOL) call on D-PLEX100 for the prevention of surgical site infections on Tuesday, December 15, 2020, at 8:00 am Eastern Time.

 

The call will feature presentations by KOLs Hartzell V. Schaff, MD, Mayo Clinic, Anthony J. Senagore, MD, Formerly of UTMB at Galveston, and Oded Zmora, MD, Shamir Medical Center, Israel, who will discuss the burden and challenges related to surgical site infections (SSIs) post colorectal and cardiovascular surgeries and the opportunity for D-PLEX100 to change the current status quo for the better. Dr. Schaff, Dr. Senagore, and Dr. Zmora will be available to answer questions following the formal presentations.

 

PolyPid’s management team will also discuss its developmental plans for D-PLEX100.

Nov 4 - Nov 17, 2020

PETAH TIKVA, Israel, Nov. 04, 2020 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD), a Phase 3 clinical-stage biopharmaceutical company focused on developing targeted, locally administered and prolonged-release therapeutics using its proprietary PLEX technology, today announced that it will present at two investor conferences in November. Details on the presentations can be found below. The company will also participate in one-on-one investor meetings at the AGP Virtual Healthcare Symposium 2020 on Thursday, November 19.

 

H.C. Wainwright 6th Annual Israel Conference

Date:  Thursday, November 12, 2020
Time: 1:30 PM Eastern Time

 

Stifel 2020 Virtual Healthcare Conference

Date:  Tuesday, November 17, 2020
Time: 8:00 AM Eastern Time
Webcast: https://wsw.com/webcast/stifel27/pypd/2115344 

Jun 6 - Jun 10, 2020
PolyPid’s abstract "Local Constant Prolonged Release of an Antibiotic for the Prevention of Surgical Site Infections (SSI) Post Colorectal Resection Abdominal Surgeries" was accepted for quick Shot Presentation during ASCRS’ Annual Scientific Meeting. Due to the COVID-19 pandemic the personal meeting was cancelled, however, PolyPid's slides and voice narration, presented by Dr. Anthony Senagore, will remain posted on the ASCRS virtual meeting website from June 6th until the 2021 ASCRS Annual Scientific Meeting in April.

Sep 25 - Sep 28, 2020
PolyPid’s abstract "Improved healing of severe open long bone fractures treated with antibiotic-formulated bone graft during the first surgical intervention post-injury" was accepted for Oral presentation at the 2019 OTA Annual Meeting, to be held in Colorado, Denver, on September 25-28, 2019. The Oral Free Paper will be presented by Prof. Doron Norman, in Paper Session II: Tibia and Knee/Tibial Plateau, on Fri., 9/27/19 at 10:16 AM - 10:22 AM.  

Nov 25 - Nov 28, 2018
PolyPid will present its product candidate D-PLEX intended to treat peri-implantitis,  in booth no. 413 at the Israeli pavilion, in the Greater New York Dental Meeting, to be held on November 25th - 28th 2018, in the Jacob K. Javits Convention Center, 11th Ave B/W 34th & 39th Street, David Intercontinental hotel, New York.

Oct 10 - Oct 13, 2018
PolyPid’s abstract “Enhanced bone healing of Gustilo III severe open tibia fractures treated by immediate antibiotic-formulated bone grafting” was accepted for Oral presentation at the 39th SICOT Orthopaedic World Congress, to be held in Montreal, Canada, from 10-13 October 2018. The Oral Free Paper will be presented by Dr. Noam Emanuel, PolyPid’s CTO, as a part of the Trauma Free Papers (Pelvis/Lower Limb) session, currently due to take place on 10/12/2018 at 16:00 - 17:30 in Room 517d.

Oct 7 - Oct 9, 2018
PolyPid’s abstract “PLEX technology - A lipid-and-polymer-based novel local drug delivery system - from concept to clinical practice” was accepted for Oral presentation at the 11th meeting of the ICRS, to be held on October 7-9, 2018, at the Hacienda Forest View Hotel, Ma'alot Tarshiha. The presentation is scheduled for Sunday, October 7, 2018 from 15:20 until 15:35  in the session entitled:  INNOVATIVE BIO-INSPIRED AND BIOMIMETIC MATERIALS.

Technology

PolyPid’s PLEX targeted drug delivery platform enables localized, controlled, continuous release of medication over prolonged periods of time for better patient outcomes.

Read More >
D-PLEX100

D-PLEX100

Provides safe and effective local antibiotic protection against SSI (surgical Site Infection) at the needed tissues or organs by administration during surgical procedures.

Read More >
D-PLEX1000

D-PLEX1000

Comprised of antibiotic eluting ß tri-calcium phosphate (ßTCP) granules, designed for bone related infections applications.

Read More >